Skip to content

Effect of Products on skin ageing

To evaluate the safety and efficacy of a skin care formulation in terms of skin firmness, elasticity, hydration,brightness, skin shine glow and reduction in pore size on healthy human subjects. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073049
Enrollment
36
Registered
2024-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Toner: The Product is applied on whole face, frequency of application is twice in a day for the period of 28 days Control Intervention1: Nil: NA

Sponsors

Herbalife
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Indian / Asian male and female subjects 2)Healthy subjects 3)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar) 4)Having varied skin types (ideally equal representation of all 4 skin types – Oily, Normal, Dry and Combination) 5)Having visible pores on face as determined by the dermatologist.

Exclusion criteria

Exclusion criteria: 1)For females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2) Having refused to give his/her assent by not signing the consent form 3)Taking part in another study liable to interfere with this study 4)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area 5)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 6)Having a progressive asthma (either under treatment or last fit in the last 2 years) 7)Being epileptic. 8)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 9)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products. 10)Under a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). 11) Having cutaneous hypersensitivity. 12)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 13)Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit. 14) Having applied a cosmetic product (included make-up) on the studied areas during study evaluations.

Design outcomes

Secondary

MeasureTime frame
NilTimepoint: NA

Primary

MeasureTime frame
Skin firmness, elasticity, hydration, brightness, skin shine/glow and reduction in pore sizeTimepoint: Baseline, Immediate after product application, 2 hours, 14 days, 28 days

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

poojayadav@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026